Jefferies Financial Group Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Jefferies Financial Group Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$13.58 - $17.36 $1.29 Million - $1.65 Million	-95,000 Reduced 10.35%	822,515 $12.9 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $1.81 Million - $2.96 Million	178,772 Added 24.2%	917,515 $14.8 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $3.84 Million - $4.78 Million	308,475 Added 71.69%	738,743 $9.4 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $9.89 Million - $11.9 Million	-744,850 Reduced 63.39%	430,268 $6.06 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $14.1 Million - $21.8 Million	985,302 Added 519.08%	1,175,118 $18.2 Million
Q4 2022 Sep 21, 2023	SELL	$14.85 - $19.04 $3.79 Million - $4.86 Million	-255,150 Reduced 59.3%	175,118 $2.87 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $2.82 Million - $3.61 Million	189,816 New	189,816 $3.11 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.